Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Rhodopirellula baltica SH 1T is a marine member of the phylum Planctomycetes isolated from the Kiel Fjord in the Baltic Sea. It possesses several unique characteristics that make it valuable for research, including peptidoglycan-free proteinaceous cell walls, intracellular compartmentalization, and reproduction via budding that results in a life cycle with both motile and sessile morphotypes . The organism's genome contains many biotechnologically promising features, including unique sulfatases, carbohydrate-active enzymes, and a distinctive C1-metabolism pathway . These features, along with its ability to adapt to various environmental conditions, make R. baltica an interesting source for recombinant protein expression studies.
When designing culture conditions, it's important to note that supplementation with certain carbon sources like NAG can trigger biofilm formation in R. baltica, resulting in a decrease in culture optical density . This phenomenon should be considered when planning growth experiments for protein extraction.
| Medium Type | Composition | Growth Characteristics | Applications |
|---|---|---|---|
| MM2 (Maintain Medium 2) | Chemically defined, carbon-free | Survival without growth | Controlled studies |
| MM2 + Glucose | MM2 with glucose | Moderate growth | Metabolic studies |
| MM2 + NAG | MM2 with N-acetylglucosamine | Moderate growth, biofilm formation | Biofilm studies |
| M2 medium broth | Complex marine medium | Optimal growth | Biomass production |
Flavohemoproteins (hmp) are bacterial proteins containing both flavin and heme domains. These proteins are widely distributed across bacterial species and typically serve several critical functions:
Detoxification of nitric oxide (NO) through dioxygenase activity
Oxygen sensing and signaling
Protection against nitrosative stress
Participation in redox reactions
The structure typically consists of a globin domain containing a b-type heme at the N-terminus and a flavin-binding reductase domain at the C-terminus. The reductase domain usually binds FAD (flavin adenine dinucleotide) and can utilize NAD(P)H as an electron donor. In the case of R. baltica, the flavohemoprotein would likely play roles in adaptation to varying oxygen levels and protection against nitrosative stress in the marine environment.
R. baltica exhibits a complex life cycle similar to Caulobacter crescentus, with distinct morphological stages that affect gene expression patterns . Transcriptomic analysis has revealed significant differences in gene expression throughout the growth cycle:
Early exponential phase (44h): Dominated by swarmer and budding cells with high expression of genes related to DNA replication, amino acid metabolism, and carbohydrate metabolism
Mid-exponential phase (62h): Decreased expression of metabolism-related genes
Transition phase (82h): Increased expression of stress response genes and cell wall-related genes
Stationary phase (96h+): Dominated by rosette formations with significant upregulation of genes for energy production, amino acid biosynthesis, signal transduction, stress response, and protein folding
When designing experiments to express and extract flavohemoprotein from R. baltica, researchers should consider these growth phase-specific expression patterns. The timing of harvest will significantly impact protein yield and potentially the post-translational modifications present in the target protein.
| Growth Phase | Cell Morphology | Upregulated Gene Categories | Downregulated Gene Categories | % Regulated Genes |
|---|---|---|---|---|
| Early Exponential (44h vs 62h) | Swarmer and budding cells | DNA replication, Amino acid metabolism, Carbohydrate metabolism | - | 2% |
| Mid-Exponential (62h) | Mixed morphology | - | Oxidases, Peptidases, Lipases | 1% |
| Transition (82h vs 62h) | Single cells, budding cells, rosettes | Glutamate dehydrogenase, Stress response proteins | - | 3% |
| Stationary (240h vs 82h) | Mostly rosettes | Energy production, Amino acid biosynthesis, Stress response, Protein folding | Carbon metabolism, Translation control | 12% |
When expressing recombinant R. baltica flavohemoprotein, researchers should consider several factors to optimize production:
Host selection: E. coli is the most common heterologous host, but its cytoplasmic environment differs significantly from R. baltica. Consider using marine bacterial expression systems or salt-tolerant E. coli strains.
Codon optimization: R. baltica's GC content and codon usage may differ from standard expression hosts. Synthetic gene constructs with optimized codons can significantly improve expression.
Fusion partners: Adding solubility-enhancing tags (MBP, SUMO, TrxA) can improve protein folding and solubility. For flavohemoproteins, ensure that fusion partners do not interfere with heme or flavin incorporation.
Media supplementation: Add δ-aminolevulinic acid (0.5-1.0 mM) to enhance heme biosynthesis and riboflavin (10-20 μM) to improve flavin incorporation during expression.
Induction conditions: Lower temperatures (16-20°C) and longer induction times (overnight) often improve the folding of complex multi-domain proteins like flavohemoproteins.
The adaptation of R. baltica to salt conditions suggests that expression in the presence of NaCl (0.5-3% w/v) may help maintain proper protein folding and incorporation of cofactors .
Purification of functional R. baltica flavohemoprotein requires special attention to maintain the integrity of both the heme and flavin domains:
Buffer composition: Include salt (250-500 mM NaCl) to mimic the marine environment of R. baltica. Maintain pH between 7.0-8.0 to preserve both heme and flavin domains.
Reducing agents: Include mild reducing agents (1-5 mM β-mercaptoethanol or 0.5-1 mM DTT) to prevent oxidation of sensitive residues, but avoid stronger reducing agents that might affect the heme iron.
Chromatography sequence:
Initial capture: Immobilized metal affinity chromatography (IMAC) for His-tagged proteins
Intermediate purification: Ion exchange chromatography (typically Q-Sepharose at pH 8.0)
Polishing: Size exclusion chromatography to separate aggregates and ensure homogeneity
Spectroscopic monitoring: Monitor the heme:protein ratio by measuring the absorbance ratio (A410/A280) throughout purification. Well-incorporated heme typically gives a ratio of 1.0-1.5.
Storage conditions: Store purified protein with 10% glycerol at -80°C. Avoid repeated freeze-thaw cycles which can cause loss of heme and flavin cofactors.
Given that R. baltica proteins show different expression patterns under various growth conditions , assess protein stability and activity immediately after purification to ensure functional integrity.
Comprehensive characterization of R. baltica flavohemoprotein requires multiple spectroscopic approaches:
UV-Visible Spectroscopy:
Oxidized heme typically shows a Soret band at ~410 nm and Q bands at 530-570 nm
Reduced heme exhibits a shifted Soret band (~420 nm) and altered Q bands
Flavin domain shows characteristic peaks at 370-450 nm
Monitor ligand binding (NO, CO, O₂) through spectral shifts
Resonance Raman Spectroscopy:
Provides information about heme coordination state and protein interactions
Detects structural changes upon ligand binding
Identifies the spin and oxidation state of the heme iron
Electron Paramagnetic Resonance (EPR):
Characterizes the electronic structure of the heme iron
Detects formation of radical species during catalysis
Provides information about the coordination environment
Circular Dichroism (CD):
Far-UV (190-250 nm): Secondary structure composition
Near-UV (250-320 nm): Tertiary structure around aromatic residues
Visible (350-600 nm): Heme and flavin environments
| Method | Information Obtained | Technical Parameters | Sample Requirements |
|---|---|---|---|
| UV-Visible | Redox state, Ligand binding | 250-700 nm scan range, 1 nm resolution | 1-10 μM protein, 1 ml volume |
| Resonance Raman | Heme coordination, Fe-ligand bonds | Excitation at 413 nm, 10-20 mW power | 50-100 μM protein, 50 μl volume |
| EPR | Fe oxidation/spin state | X-band (9 GHz), 4-100K temperature | 100-200 μM protein, 200 μl volume |
| CD | Secondary structure, Cofactor environment | 0.1 cm path length, N₂-purged chamber | 0.1-1.0 mg/ml protein, 200 μl volume |
To investigate the NO detoxification function of R. baltica flavohemoprotein, design experiments that address both the enzymatic mechanism and the physiological relevance:
NO Consumption Assays:
Use an NO-specific electrode to directly measure NO consumption rates
Compare activity under aerobic vs. microaerobic conditions
Determine kinetic parameters (Km for NO typically 0.1-1.0 μM)
Test the effect of different electron donors (NADH vs. NADPH)
Product Analysis:
Quantify nitrate formation using ion chromatography or colorimetric methods
Determine the stoichiometry of NO:O₂ consumption (theoretical 1:1 ratio)
Use isotopically labeled NO (¹⁵NO) and analyze products by mass spectrometry
Electron Transfer Studies:
Monitor NAD(P)H oxidation at 340 nm concurrently with NO consumption
Calculate coupling efficiency between electron consumption and NO oxidation
Investigate the effect of flavin domain mutations on electron transfer rates
Physiological Relevance:
Compare activity at different salt concentrations to mimic marine conditions
Test activity at temperatures relevant to R. baltica's habitat (4-25°C)
Examine pH dependence across the range found in marine environments (pH 7.5-8.4)
Given R. baltica's adaptation to marine environments, particular attention should be paid to the salt dependence of flavohemoprotein activity, as high salt concentrations may affect protein-protein interactions and substrate binding.
Understanding the structural dynamics of R. baltica flavohemoprotein requires integrating multiple experimental approaches:
X-ray Crystallography:
Obtain structures of different functional states (apo, holo, substrate-bound)
Use micro-seeding techniques to improve crystal quality
Consider crystallization with stabilizing ligands (e.g., imidazole, CO)
Attempt time-resolved crystallography with NO or O₂ to capture reaction intermediates
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Map solvent accessibility changes upon substrate binding
Identify flexible regions that may be involved in domain communication
Compare exchange rates in different functional states
Analyze the effect of salt concentration on protein dynamics
Small-Angle X-ray Scattering (SAXS):
Determine solution structure and conformational changes
Characterize domain arrangements in different states
Assess oligomerization state under varying conditions
Provide constraints for computational modeling
Single-Molecule FRET:
Engineer cysteine pairs for fluorophore attachment at domain interfaces
Monitor inter-domain distance changes during catalysis
Detect conformational heterogeneity in the protein population
Assess the effect of substrates on protein conformational dynamics
Molecular Dynamics Simulations:
Model protein behavior in explicit solvent with appropriate ion concentrations
Simulate gas diffusion pathways for NO and O₂
Identify conserved water networks and salt bridges
Predict the effect of marine conditions on protein flexibility
Site-directed mutagenesis provides powerful insights into structure-function relationships in flavohemoproteins:
Key Residues to Target:
Proximal histidine: The heme iron coordinating residue (typically His) is essential for proper heme binding and reactivity
Distal pocket residues: Amino acids that stabilize bound ligands (typically Tyr, Gln, or Arg)
FAD-binding residues: Conserved motifs that anchor the flavin cofactor
Domain interface: Residues that facilitate electron transfer between domains
NADH-binding site: Residues involved in electron donor recognition
Mutation Design Strategy:
Conservative mutations: Replace with similarly sized residues to probe specific interactions (e.g., His→Asn, Tyr→Phe)
Charge alterations: Modify electrostatic interactions (e.g., Arg→Ala, Glu→Gln)
Size variations: Alter steric constraints (e.g., Val→Ile, Ala→Val)
Polarity changes: Modify hydrogen bonding networks (e.g., Ser→Ala, Thr→Val)
Functional Assays for Mutants:
Heme and flavin incorporation: Spectroscopic analysis of cofactor binding
NO dioxygenase activity: Measure activity changes in mutants
Electron transfer efficiency: Compare NADH oxidation rates
Ligand binding kinetics: Determine kon and koff rates for NO and O₂
Protein stability: Thermal denaturation studies to assess structural integrity
| Target Region | Residue Function | Suggested Mutations | Expected Effect | Assessment Method |
|---|---|---|---|---|
| Heme Pocket | Fe coordination | His→Ala, His→Cys | Loss of heme binding | UV-Vis spectroscopy |
| Distal Pocket | Ligand stabilization | Tyr→Phe, Gln→Asn | Altered NO affinity | Stopped-flow kinetics |
| FAD Binding | Flavin positioning | Ser→Ala, Arg→Lys | Reduced FAD incorporation | Fluorescence |
| Domain Interface | Electron transfer | Asp→Asn, Glu→Gln | Slower catalysis | Steady-state kinetics |
| NADH Binding | Cofactor specificity | Gly→Ala, Ser→Thr | Changed NADH vs. NADPH preference | Activity assays |
Rhodopirellula baltica is known to produce various secondary metabolites whose production can be influenced by different carbon sources and growth conditions . This metabolite production can significantly impact recombinant protein expression:
Carbon Source Effects:
Growth Phase Considerations:
Secondary metabolite production changes significantly between growth phases
The transition from exponential to stationary phase shows the most dramatic shifts in metabolite profiles
Timing recombinant protein induction to specific growth phases can help manage interference from secondary metabolites
Antimicrobial Compounds:
Mitigation Strategies:
Use adsorption resins (e.g., XAD) in the culture medium to continuously remove potentially interfering secondary metabolites
Select carbon sources that minimize production of interfering compounds
Consider two-phase fermentation strategies to separate growth and protein production phases
The ability of R. baltica to produce diverse secondary metabolites under different conditions highlights the importance of carefully optimizing expression conditions when producing recombinant proteins from this organism.
Recombinant R. baltica flavohemoprotein offers several promising research applications:
Environmental Sensing Tools: The protein's ability to respond to NO and O₂ levels makes it valuable for developing biosensors for marine environmental monitoring.
Biocatalysis: The dual-domain nature with both oxidoreductase and NO dioxygenase activities offers potential for stereoselective biotransformations in pharmaceutical synthesis.
Stress Response Models: As a model for studying bacterial adaptation to nitrosative and oxidative stress in marine environments, particularly under changing ocean conditions.
Protein Engineering Platform: The unique properties of a flavohemoprotein from a marine Planctomycetes provide a novel starting point for protein engineering to develop enzymes with enhanced stability in high-salt conditions.
Structural Biology: The study of domain communication between heme and flavin domains contributes to our understanding of complex multi-domain proteins and allostery.
These applications leverage the unique properties of R. baltica as a marine Planctomycetes with distinctive cellular features and potential for producing bioactive compounds .
Several key research directions would significantly advance our understanding of R. baltica flavohemoprotein:
Ecological Role Investigation: Determine how the flavohemoprotein contributes to R. baltica's adaptation to diverse marine environments and its role in the organism's unique life cycle.
Comparative Analysis: Conduct systematic comparisons with flavohemoproteins from other marine bacteria to identify adaptations specific to the Planctomycetes phylum.
In vivo Studies: Develop genetic tools for R. baltica to enable gene knockout and complementation studies to determine the physiological role of flavohemoprotein.
Structural Determination: Resolve high-resolution structures in different functional states to understand the conformational changes during catalysis.
Salt Adaptation Mechanisms: Investigate how the protein maintains structure and function under marine salt conditions, potentially identifying novel stabilization strategies.
Biotechnological Applications: Explore the potential of R. baltica flavohemoprotein for applications in bioremediation of NO-contaminated environments or as biocatalysts in pharmaceutical synthesis.